RPG Life Sciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	1,832	876.6	676.4	514.8	400
Depreciation & Amortization	211.5	164.5	146.9	148.5	157.3
Other Amortization	2.8	6.2	8.1	8.1	7.4
Loss (Gain) From Sale of Assets	-12	-0.1	7.8	-	0.1
Loss (Gain) From Sale of Investments	-69.6	-57.7	-14.4	-8.9	-
Provision & Write-off of Bad Debts	-16.2	27	5	0.9	0.8
Other Operating Activities	-909.8	-2	-32.1	15.2	52.4
Change in Accounts Receivable	-357.5	-142.5	-54	248.1	62.2
Change in Inventory	61.9	-59.5	-120.6	-246.6	-117.2
Change in Accounts Payable	95.4	63.3	192.6	-19.1	31.2
Change in Other Net Operating Assets	-60.3	67.8	92.5	-13.5	-11.5
Operating Cash Flow	778.6	943.6	908.2	647.5	582.7
Operating Cash Flow Growth	-17.49%	3.90%	40.26%	11.12%	16.14%
Capital Expenditures	-360.3	-692.3	-327.3	-239.5	-85.1
Sale of Property, Plant & Equipment	1,095	1.5	0.8	-	0.5
Investment in Securities	-287.9	-269.6	-569.9	-119.7	-
Other Investing Activities	-864.5	168.9	-161.7	12.6	5
Investing Cash Flow	-418	-791.5	-1,058	-346.6	-79.6
Short-Term Debt Repaid	-	-	-2.7	-3.1	-46
Long-Term Debt Repaid	-	-0.1	-6.6	-7.7	-51
Total Debt Repaid	-	-0.1	-9.3	-10.8	-97
Net Debt Issued (Repaid)	-	-0.1	-9.3	-10.8	-97
Common Dividends Paid	-264.6	-198.5	-158.8	-119.1	-
Other Financing Activities	-6.2	-4.5	-3.1	-5.2	-7.9
Financing Cash Flow	-270.8	-203.1	-171.2	-135.1	-104.9
Miscellaneous Cash Flow Adjustments	-	-	-0.1	-	-
Net Cash Flow	89.8	-51	-321.2	165.8	398.2
Free Cash Flow	418.3	251.3	580.9	408	497.6
Free Cash Flow Growth	66.45%	-56.74%	42.38%	-18.01%	26.20%
Free Cash Flow Margin	6.40%	4.32%	11.33%	9.27%	12.79%
Free Cash Flow Per Share	25.29	15.19	35.12	24.67	30.09
Cash Interest Paid	6.2	4.5	3.1	5.2	7.9
Cash Income Tax Paid	527.5	293.1	252.3	188.5	83.3
Levered Free Cash Flow	325.59	222.04	487.99	350.38	367.74
Unlevered Free Cash Flow	329.46	224.85	489.93	353.63	372.68
Change in Working Capital	-260.5	-70.9	110.5	-31.1	-35.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.